Skip to main content
Article thumbnail
Location of Repository

Challenges in mass drug administration for treating lymphatic filariasis in Papua, Indonesia.

By Navneet Bhullar and Jacob Maikere


ABSTRACT: BACKGROUND: The World Health Organization (WHO) Global Program to Eliminate Lymphatic Filariasis relies on mass drug administration (MDA) of two drugs annually for 4 to 6 years. The goal is to reduce the reservoir of microfilariae in the blood to a level insufficient to maintain transmission by the mosquito vector. In 2008, the international medical aid organization Medecins Sans Frontieres (MSF) performed the first round of a MDA in the high-burden area of Asmat district, in Papua, Indonesia. We report the challenges faced in this MDA on a remote Indonesian island and propose solutions to overcome these hurdles in similar future contexts. RESULTS: During the MDA, we encountered difficult challenges in accessing as well as persuading the patient population to take the antifilarial drugs. Health promotion activities supporting treatment need to be adapted and repetitive, with adequate time and resources allocated for accessing and communicating with local, seminomadic populations. Distribution of bednets resulted in an increase in MDA coverage, but it was still below the 80-85% target. CONCLUSIONS: MDA for lymphatic filariasis is how the WHO has planned to eliminate the disease from endemic areas. Our programmatic experience will hopefully help inform future campaign planning in difficult-to-access, high-burden areas of the world to achieve target MDA coverage for elimination of lymphatic filariasis

Year: 2010
DOI identifier: 10.1186/1756-3305-3-70
OAI identifier:
Provided by: MSF Field Research

Suggested articles


  1. (1998). Candidate parasitic diseases. Bull World Health Organ
  2. (1997). Coelho G: Lymphatic filariasis: a potentially eradicable disease. Cad Saude Publica
  3. (2004). Evaluation of the Lymphatic Filariasis Control Program, Samarai Murua District,
  4. (2003). Organization: Global Programme to Eliminate Lymphatic Filariasis. Annual Report on Lymphatic Filariasis
  5. (2004). Organization: Lymphatic filariasis: progress of disability prevention activities. Wkly Epidemiol Rec
  6. (2005). Organization: Monitoring and epidemiological assessment of the programme to eliminate lymphatic filariasis at implementation unit - 18 -level.
  7. Organization: The Global Programme to Eliminate Lymphatic Filariasis []
  8. (1997). Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ
  9. (1999). The role of albendazole in programmes to eliminate lymphatic filariasis. Parasitol Today

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.